These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Comparative study of the pharmacokinetic profiles of two LMWHs--bemiparin (3500 IU, anti-Xa) and tinzaparin (4500 IU, anti-Xa)--administered subcutaneously to healthy male volunteers. Depasse F, González de Suso MJ, Lagoutte I, Fontcuberta J, Borrell M, Samama MM. Thromb Res; 2003 Jan 25; 109(2-3):109-17. PubMed ID: 12706639 [Abstract] [Full Text] [Related]
23. Tissue factor pathway inhibitor release induced by defibrotide and heparins. Cella G, Sbarai A, Mazzaro G, Motta G, Carraro P, Andreozzi GM, Hoppensteadt DA, Fareed J. Clin Appl Thromb Hemost; 2001 Jul 25; 7(3):225-8. PubMed ID: 11441984 [Abstract] [Full Text] [Related]
27. Clinical evaluation of a new one-stage clotting assay for heparin and low molecular weight heparins. Harenberg J. J Mal Vasc; 1987 Jul 25; 12 Suppl B():68-70. PubMed ID: 2834495 [Abstract] [Full Text] [Related]
28. Inhibition of low molecular weight heparin by protamine chloride in vivo. Harenberg J, Gnasso A, de Vries JX, Zimmermann R, Augustin J. Thromb Res; 1985 Apr 01; 38(1):11-20. PubMed ID: 4002198 [Abstract] [Full Text] [Related]
29. Differential effect of unfractionated heparin and low molecular weight heparin on intravascular tissue factor pathway inhibitor: evidence for a difference in antithrombotic action. Hansen JB, Sandset PM, Huseby KR, Huseby NE, Bendz B, Ostergaard P, Nordøy A. Br J Haematol; 1998 Jun 01; 101(4):638-46. PubMed ID: 9674734 [Abstract] [Full Text] [Related]
33. Effects of a synthetic factor Xa inhibitor (JTV-803) on various laboratory tests. Tobu M, Iqbal O, Hoppensteadt DA, Shultz C, Jeske W, Fareed J. Clin Appl Thromb Hemost; 2002 Oct 01; 8(4):325-36. PubMed ID: 12516682 [Abstract] [Full Text] [Related]
34. Efficacy of unfractionated heparin, low molecular weight heparin and both combined for releasing total and free tissue factor pathway inhibitor. Altman R, Scazziota A, Rouvier J. Haemostasis; 1998 Oct 01; 28(5):229-35. PubMed ID: 10420071 [Abstract] [Full Text] [Related]
37. Anticoagulant effects of inhaled unfractionated heparin in the dog as determined by partial thromboplastin time and factor Xa activity. Manion JS, Thomason JM, Langston VC, Claude AK, Brooks MB, Mackin AJ, Lunsford KV. J Vet Emerg Crit Care (San Antonio); 2016 Oct 01; 26(1):132-6. PubMed ID: 26194053 [Abstract] [Full Text] [Related]
38. Studies on the neutralizing effects of protamine on unfractionated and low molecular weight heparin (Fragmin) at the site of activation of the coagulation system in man. Wolzt M, Weltermann A, Nieszpaur-Los M, Schneider B, Fassolt A, Lechner K, Eichler HG, Kyrle PA. Thromb Haemost; 1995 Mar 01; 73(3):439-43. PubMed ID: 7667826 [Abstract] [Full Text] [Related]
39. Evaluation of an oral direct factor Xa inhibitor anticoagulant in healthy adult horses. Rodríguez-Pozo ML, Armengou L, Monreal L, Viu J, Cesarini C, Jose-Cunilleras E. J Vet Emerg Crit Care (San Antonio); 2017 Jan 01; 27(1):82-88. PubMed ID: 27712038 [Abstract] [Full Text] [Related]